<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00142441</url>
  </required_header>
  <id_info>
    <org_study_id>63/2003</org_study_id>
    <nct_id>NCT00142441</nct_id>
  </id_info>
  <brief_title>Effect of Pulse Width on Scar Treatment Using a 595-nm Pulsed Dye Laser</brief_title>
  <official_title>Effect of Pulse Width of a 595-nm Flashlamp-pumped Pulsed-dye Laser on the Treatment Response of Keloidal and Hypertrophic Sternotomy Scars</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dermatological Society of Thailand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mahidol University</source>
  <brief_summary>
    <textblock>
      To investigate the effect of pulse width on the treatment response of keloidal and&#xD;
      hypertrophic sternotomy scars to a 595-nm pulsed dye laser&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The pulse width of the previous model of pulsed dye laser was fixed at 0.45 millisecond,&#xD;
      whereas the pulse widths of the latest model of PDL are tunable ranging between 0.45-40&#xD;
      milliseconds. The long-pulsed PDL has been proven to be safe and more effective in treating&#xD;
      certain vascular abnormalities including adult port-wine-stain and small leg vein.9-12 In the&#xD;
      present study, we would like to investigate the effect of pulse widths on the treatment&#xD;
      response of keloidal and hypertrophic sternotomy scars to the 595-nm PDL.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2003</start_date>
  <completion_date>December 2004</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>scar volume, scar height, scar color, scar elasticity were measured at baseline (day of laser treatment 1), Week 4 (day of laser treatment 2), Week 8 (day of laser treatment 3), Week 24 (12 weeks after the last treatment).</measure>
  </primary_outcome>
  <enrollment>19</enrollment>
  <condition>Keloids</condition>
  <condition>Hypertrophic Scars</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pulsed dye laser</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy, adult subjects aged above 18.&#xD;
&#xD;
          -  Subjects must be in good health as determined by the investigator.&#xD;
&#xD;
          -  Presence of keloidal and hypertrophic sternotomy scars for at least 6 months&#xD;
&#xD;
          -  Subjects must have no prior treatment of the scar within 1 month before the first&#xD;
             treatment session.&#xD;
&#xD;
          -  Subject or authorized representative must sign Informed Consent Form prior to study&#xD;
             enrollment.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Female subjects known to be pregnant.&#xD;
&#xD;
          -  Subjects with scleroderma, connective tissue disorders, hematologic disorders,&#xD;
             hepatitis, infection, or uncontrolled diabetes mellitus.&#xD;
&#xD;
          -  Subjects with photosensitive dermatoses such as Systemic Lupus Erythematosus (SLE)&#xD;
&#xD;
          -  Subjects with a documented positive HIV test.&#xD;
&#xD;
          -  Subjects who are on any types of anticoagulants.&#xD;
&#xD;
          -  Subjects who are habitual smokers of cigars, pipe tobacco, or cigarettes.&#xD;
&#xD;
          -  Subjects with history of radiation treatment at treatment sites.&#xD;
&#xD;
          -  Subjects who use of any types of treatment of scars at the treatment site within one&#xD;
             month before the first treatment visit.&#xD;
&#xD;
          -  Subjects who are on medication that may interfere with wound healing or hemostasis.&#xD;
&#xD;
          -  Subjects that have not signed the Informed Consent Form.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Woraphong - Manuskiatti, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Siriraj Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Medicine Siriraj Hospital</name>
      <address>
        <city>Bangkoknoi</city>
        <state>Bangkok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol. 2002 Sep;138(9):1149-55.</citation>
    <PMID>12224975</PMID>
  </reference>
  <verification_date>June 2016</verification_date>
  <study_first_submitted>September 1, 2005</study_first_submitted>
  <study_first_submitted_qc>September 1, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 2, 2005</study_first_posted>
  <last_update_submitted>June 1, 2016</last_update_submitted>
  <last_update_submitted_qc>June 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2016</last_update_posted>
  <keyword>Pulsed dye laser</keyword>
  <keyword>Keloids</keyword>
  <keyword>Hypertrophic scars</keyword>
  <keyword>Pulse width</keyword>
  <keyword>Pulse duration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keloid</mesh_term>
    <mesh_term>Hypertrophy</mesh_term>
    <mesh_term>Cicatrix, Hypertrophic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

